Tilmicosin is a macrolide antibiotic developed for veterinary use. It is recommended for treatment and prevention of pneumonia in cattle, sheep and pigs, associated with Pasteurella haemolytica, P. multocida, Actinobacillus pleuropneumoniae, mycoplasma species and other microorganisms found sensitive to this compound.

FUNCTION                                

1. Timicoxacin has an antibacterial profile similar to that of thalectin, but with an enhanced effect against Pasteurella multocida and Pasteurella haemolyticus.

Because of its special antibacterial activity and pharmacokinetic characteristics, the drug has been approved for clinical use in the prevention and treatment of infectious diseases in cattle, goats, sheep, cows, pigs, chickens and other animals. Especially animal respiratory diseases, such as livestock actinomycosis pleural pneumonia, pasteurella disease and chicken mould body disease and lactation animal mastitis treatment.

2. It is mainly used to treat the infection caused by pleural pneumonia, actinobacillus, pasteurella and mycoplasma.

APPLICATION                           

1. Tilmicosin is a macrolide antibiotic drug, it is the upgrade product of tylosin phosphate and specially used for veterinary. It is harmfulless, residue free, with strong effection and safety.

2.It mainly cures for the respiratory disease that caused by mycoplasma, animal infective pleuropneumonia that caused by actinobacillus and pasteurella multocida and breast infection of lactational animals. The drug effect is 4 to 8 times than tylosin phosphate. It has the advantages of convenient application and less incompatibilities simultaneously.

Notice:
1.Tilmicosin formulation can not be injected for swines.  2. Forbidden for laying hens.